Meet our Scientific Advisory Committee
We receive around 400 ideas from scientists all over the world every year and we want to make sure only the most innovative, creative and exciting research is funded. That’s where our external team of cancer experts, also known as our Scientific Advisory Committee, come in.
How do we ensure we use your donations to fund the best research?
Made up of eminent cancer specialists who volunteer their time to assess, review, and judge the ideas we receive each year, our Committee select projects based on the quality of the science and the novelty of the idea.
The breadth of knowledge and depth of experience of our members ensures we only fund research of the highest calibre.
The members of our Scientific Advisory Committee all have different areas of expertise across a range of different cancer types, branches of biology, chemistry, medicine, and drug development.
These differences in perspective are crucial when it comes to deciding the best projects to support. Since we fund research involving lots of different scientific techniques and all cancer types, we need a broad and varied committee to help spot the ideas with the best chance of having real impact.
We are proud to have our Committee's expertise on board to help us evaluate and select the projects we fund with our Curestarters' generous donations.
Being the Chair of the Scientific Advisory Committee is a chance to work with all of these great scientists to identify the bold ideas - the scientists that are on the cutting-edge of how we are understanding cancer - and make sure that we are funding those that are going to make a difference.
Meet our members:
Dr Olivia Rossanese
Institute of Cancer Research, United Kingdom
Dr Vincenzo Giambra
Fondazione IRCCS Casa Sollievo della Sofferenza, Italy
Dr Sharon Rossiter
University of Hertfordshire, United Kingdom
Dr Miriam Martini
University of Turin, Italy
Professor Bruno Silva-Santos
University of Lisbon, Portugal
Dr Aura Carreira
CSIC, Madrid, Spain
Professor Pipsa Saharinen
University of Helsinki, Finland
Dr Laura Rosenberg
Astra Zeneca
Professor David Withers
University of Birmingham, United Kingdom
Professor Ruth Palmer
University of Gothenburg, Sweden
Dr Sheeba Irshad
King's College London, United Kingdom
Professor Louis Vermeulen
Genetech, USA and Academic Medical Center, Netherlands
Dr Pim French
Erasmus University Medical Center, Netherlands
Dr Maite Huarte
Centro de Investigación Médica Aplicada (CIMA), Spain
Dr Petr Cejka
Institute for Research in Biomedicine, Switzerland
Dr Renata Basto
Institut Curie, France
Professor Adrian Bracken
Trinity College Dublin, Ireland
Professor Marcos Malumbres
Vall D'Hebron Institute of Oncology (VHIO), Barcelona, and CNIO & CSIC, Madrid
Professor Jan-Jacob Schuringa
University of Groningen, Netherlands
Professor Jonine Figueroa
NIH, USA
Dr Yogesh Kulathu
University of Dundee, United Kingdom
Dr Daniel Lietha
Centro de Investigaciones Biológicas - CIB, Spain
Professor Simon Leedham
University of Oxford, United Kingdom
